Lab Instrumentation Markets for Pharmaceuticals, Biopharmaceuticals, & CROs

29 Aug 2019

Global Site License

Nearly a third of the market for lab instruments is for equipment applied to the pharmaceutical sector. Laboratory instrumentation is ubiquitous throughout all stages of drug development, aiding scientists involved in a wide variety of workflows, including drug discovery, clinical trials, translational research, and the quality control testing of input materials and finished products. The inherent need for precise and accurate data on pharmaceutical and biotherapeutic compounds throughout their development, combined with the strict regulatory environment, ensures that laboratory testing of these materials sits at the forefront of analytical science and innovation.

Lab Instrumentation Markets for Pharmaceuticals, Biopharmaceuticals, & CROs is an in-depth examination at the major technologies used in the pharma/bio sector, encompassing 64 technologies in 10 categories. The report also covers usage at contract research organizations (CROs). The report examines historical growth and provides forecasts for demand over the next five years. End user perspectives gained through a survey of 172 researchers in the sector provide insights into development pipelines, laboratory budgets, and the challenges being faced in therapeutics development.

The report covers the following technology categories:
• Overall Pharma/Bio Sector Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Atomic Spectroscopy Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Chromatography Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• General Analytical Techniques Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Lab Automation & Software Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Lab Equipment Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Life Science Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Mass Spectrometry Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Materials Characterization Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Molecular Spectrometry Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company
• Surface Science Instrumentation Market by Technology, by Region, by User Type (Small Molecule, Biopharma, CRO), by Company

For the companies that supply these analytical tools, demand from this space has been its largest engine of growth over the last couple decades. Future market expansion from pharma/bio continues to be very promising as well, especially as analytical techniques evolve to accommodate high throughput testing, automation, precision medicine, and increased reliance on CROs.

Companies Covered in the Report Include:
• Agilent
• Becton Dickinson
• Bio-Rad
• Bruker
• Danaher
• GE Healthcare
• Illumina
• Mettler Toledo
• MilliporeSigma
• PerkinElmer
• QIAGEN
• Shimadzu
• Thermo Fisher
• Waters

 

Page Count: 196